AIP
ELV icon

Arrowpoint Investment Partners’s Elevance Health ELV Stock Holding History

Arrowpoint Investment Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,200
Closed -$1.03M – 113
2025
Q3 		$1.03M Buy
+3,200
New +$995K 1.03% 28
2025
Q2 		– Sell
-1,200
Closed -$522K – 345
2025
Q1 		$522K Buy
+1,200
New +$482K 0.06% 364

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Arrowpoint Investment Partners's ELV Position: Q1 2025 in Review

Arrowpoint Investment Partners sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 700 shares — an estimated $281K sold.

Arrowpoint Investment Partners first reported a position in ELV in Q4 2024 and held it in 1 quarter. The position peaked at $258K in Q4 2024. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Arrowpoint Investment Partners reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 700 Elevance Health shares in Q1 2025, an estimated $281K.
  • Arrowpoint Investment Partners first reported a position in Elevance Health in Q4 2024 and held it in 1 quarter.
  • Arrowpoint Investment Partners's Elevance Health position peaked at $258K in Q4 2024.
  • 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2025, filed 13 May 2025.